We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

480 hedge funds and large institutions have $6.97B invested in Jazz Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 183 increasing their positions, 160 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

14% more repeat investments, than reductions

Existing positions increased: 183 | Existing positions reduced: 160

0.86% more ownership

Funds ownership: 92% → 92.86% (+0.86%)

2% less capital invested

Capital invested by funds: $7.12B → $6.97B (-$152M)

4% less funds holding

Funds holding: 499 → 480 (-19)

18% less call options, than puts

Call options by funds: $19.5M | Put options by funds: $23.9M

21% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 68

Holders
480
Holders Change
-19
Holders Change %
-3.81%
% of All Funds
6.91%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
54
Increased
183
Reduced
160
Closed
68
Calls
$19.5M
Puts
$23.9M
Net Calls
-$4.39M
Net Calls Change
-$11.9M

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$175M
2
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$133M
3
CCM
Camber Capital Management
Massachusetts
+$58.2M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$53.9M
5
VPC
Vestal Point Capital
New York
+$45.9M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$128M
2
Swedbank
Swedbank
Sweden
-$127M
3
AC
Armistice Capital
New York
-$80.1M
4
Morgan Stanley
Morgan Stanley
New York
-$73.3M
5
Millennium Management
Millennium Management
New York
-$69.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
RS
426
Rakuten Securities
Japan
$3.01K -$4.29K -35 -58%
UB
427
UMB Bank
Missouri
$3.01K +$2.21K +18 +257%
NS
428
NBC Securities
Alabama
$3K – – –
FCA
429
FinTrust Capital Advisors
South Carolina
$2.77K – – –
FFC
430
First Financial Corp
Indiana
$2.65K +$2.69K +22 New
CHA
431
Carmichael Hill & Associates
Maryland
$2.53K – – –
PCFFS
432
Pacific Center for Financial Services
California
$2.41K – – –
FFA
433
Farther Finance Advisors
California
$2.38K -$3.31K -27 -57%
VWA
434
Valued Wealth Advisors
Utah
$2.17K +$1.84K +15 +500%
FGAM
435
Financial Gravity Asset Management
Texas
$2.09K +$367 +3 +21%
CAM
436
ClariVest Asset Management
California
$1.93K – – –
BC
437
Barrett & Company
Rhode Island
$1.83K – – –
CFGS
438
Concourse Financial Group Securities
Alabama
$1.81K – – –
CA
439
CoreCap Advisors
Michigan
$1.81K +$1.84K +15 New
DPW
440
DiNuzzo Private Wealth
Pennsylvania
$1.45K +$245 +2 +20%
FHA
441
First Horizon Advisors
Tennessee
$1.45K – – –
NMM
442
Naples Money Management
Florida
$1.45K – – –
OLVIG
443
Oliver Lagore Vanvalin Investment Group
Michigan
$1.45K – – –
PWA
444
Provenance Wealth Advisors
Florida
$1.2K – – –
CA
445
Clearstead Advisors
Ohio
$1.13K – – –
BAM
446
Byrne Asset Management
New Jersey
$1.08K -$2.69K -22 -71%
SAM
447
Smartleaf Asset Management
Massachusetts
$1.08K +$1.1K +9 New
Lazard Asset Management
448
Lazard Asset Management
New York
$1K -$122 -1 -9%
HFS
449
Hantz Financial Services
Michigan
$1K – – –
BCMLT
450
Beacon Capital Management LLC (Tennessee)
Tennessee
$963 – – –
16 17
18
19 20

JAZZ Hedge Fund Activity: Q1 2024 in Review

480 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q1 2024, worth a combined $6.97B — down 2.1% from $7.12B a quarter earlier.

Sellers outnumbered buyers: 68 funds closed out of JAZZ and 54 opened new positions — a net loss of 14 holders — while 160 trimmed existing stakes and 183 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $175M. The largest seller was Wellington Management Group, cutting an estimated $128M.

  • 480 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q1 2024, down from 499 in Q4 2023.
  • Funds reported $6.97B of Jazz Pharmaceuticals stock for Q1 2024, down 2.1% quarter-over-quarter.
  • 54 funds opened new Jazz Pharmaceuticals positions in Q1 2024 and 68 closed out, a net change of -14 holders.
  • The largest Jazz Pharmaceuticals buyer in Q1 2024 was Capital World Investors, an estimated $175M added.
  • The largest Jazz Pharmaceuticals seller in Q1 2024 was Wellington Management Group, an estimated $128M sold.

Based on aggregated 13F filings for Q1 2024.